Stock Track | REMEGEN Soars 8.86% Amid Broader Biotech Rally in Hong Kong

Stock Track
2025/08/29

REMEGEN (09995) experienced a significant surge in its stock price, soaring 8.86% during Friday's trading session in Hong Kong. This impressive gain comes as part of a broader rally in the biotech sector, with several companies in the industry posting substantial increases.

The biotech sector in Hong Kong saw widespread gains, with companies like Cutia Therapeutics leading the pack with a 14% increase. Other notable performers included Antengene (up 13%), HBM Holdings and TransThera Sciences (both up 9%), and CARsgen Therapeutics (up 7%). REMEGEN's 8.86% rise positioned it firmly among the top performers in this sector-wide upswing, reflecting strong investor confidence in the biotech industry and REMEGEN's potential within it.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10